|
|
||||||||
Journal of Lipid Research, Vol 36, 919-930, Copyright © 1995 by Lipid Research, Inc.
P Harduin, A Tailleux, S Lestavel, V Clavey, JC Fruchart and C Fievet
We studied the effect of in vitro moderate oxidation on low density
lipoprotein (LDL) conformation and metabolism. LDL was modified with either
copper ions or phospholipase A2 plus lipoxygenase and, in both cases, mild
oxidative conditions were used. The resulting conformational changes were
investigated by studying immunological and biological properties of
oxidized LDL. The immunoreactivity of apolipoprotein (apo) B-100 was
examined using seven monoclonal antibodies. The biological implications of
conformational changes were provided by cell-lipoprotein interaction
studies using human fibroblasts and mouse peritoneal macrophages.
Enzymatically treated LDL presented a relatively less oxidative degree of
modification because it generated lower levels of TBARS, and displayed a
lower electronegativity and more comparable cellular interactions with
those of native LDL. Nevertheless, dramatic immunological changes were
measured on both forms of LDL, i.e., a significant increase in the
immunoreactivity of an epitope located in the B/E receptor binding domain,
but also at epitopes far from this site and located in the N- terminal part
of the apoB-100 molecule. The immunoreactivity of the C- terminal region
was in contrast, decreased. Yet, as compared with enzymatically oxidized
LDL, much more dramatic structural changes with chemically modified LDL
were observed, resulting in such a particular conformation of lipoprotein
that its interaction with the macrophagic scavenger receptor was favored,
but its recognition by the B/E receptor of fibroblast was abolished. In
contrast, despite a lower interaction between enzymatically modified LDL
and the B/E receptor, the metabolism of this lipoprotein was quite
comparable with that of native LDL and its degradation with cultured
macrophages was poor. The use of in vitro models is common for study of the
relationship between oxidized LDL and atherogenesis in humans. The choice
of the more appropriate way to modify lipoproteins is of interest and is
discussed.
ARTICLES
Immunological and functional properties of in vitro oxidized low density lipoprotein
Serlia et Inserm U 325, Institut Pasteur, Lille, France.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Monaco, F. Crea, G. Niccoli, F. Summaria, D. Cianflone, R. Bordone, G. Bellomo, and A. Maseri Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications Eur. Heart J., September 1, 2001; 22(17): 1572 - 1577. [Abstract] [PDF] |
||||
![]() |
H. Itabe, H. Yamamoto, M. Suzuki, Y. Kawai, Y. Nakagawa, A. Suzuki, T. Imanaka, and T. Takano Oxidized Phosphatidylcholines That Modify Proteins. ANALYSIS BY MONOCLONAL ANTIBODY AGAINST OXIDIZED LOW DENSITY LIPOPROTEIN J. Biol. Chem., December 27, 1996; 271(52): 33208 - 33217. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |